Gothenburg

Sweden

129 total trials 71 recruiting

Filter these 129 trials by phase, condition, sponsor and more.

Open in Search →

Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) Recruiting

2023-505483-11-00 6 2021-05-02 Brain abscess
GROINSS-V III Recruiting

2023-508722-99-00 4 2020-11-19 Vulvar cancer
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 9 2020-10-07 Rhabdoyosarcoma
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting

2022-501456-28-00 5 2020-07-20 atypical teratoid/rhabdoid tumours (ATRT)
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 10 2020-07-13 Acute Lymphoblastic Leukaemia
PiSCATIN - Simvastatin for the treatment of primary sclerosing cholangitis (PSC) - a randomized double-blind, placebo-controlled multicenter … Recruiting

2024-511053-22-00 4 2020-05-04 Primary sclerosing cholangitis (PSC)
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica … Recruiting

2022-501454-11-00 5 2020-02-05 standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 5 2019-08-01 Lymphoblastic lymphoma
Effects of an Opioid Sparing Care Pathway for Patients undergoing Obesity Surgery Recruiting

2023-505934-86-00 6 2019-03-26 Obesity
A study to compare conventional "salvage" radiotherapy and individualized treatment based on results from PSMA PET/CT assessments in patient … Recruiting

2023-504917-54-00 5 2018-10-30 Biochemical recurrence after prostate cancer surgery
Extension Study for Participants in Studies That Include Pembrolizumab Recruiting

2022-501254-10-00 5 2018-08-24 Advanced tumors
Nordic Pancreatic Cancer Trial (NORPACT) – 1 Recruiting

2024-517719-65-00 4 2017-02-01 Resectable pancreatic head cancer
MEMMAT - Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial Recruiting

2024-515626-92-00 4 2013-10-18 recurrent/progressive medulloblastoma, ependymoma and atypical teratoi
NOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years Recruiting

2024-518254-16-00 5 2013-03-01 Acute Myeloid Leukemia (Pediatric 0-18 years)
CLINICAL STUDY TO TEST STEM CELLS FOR THE TREATMENT OF LONG-TERM, NON-HEALING VENOUS LEG ULCERS Ended recruitment

2024-512720-11-00 5 2025-01-16 chronic venous ulcers (CVU)
ICC APL STUDY 02 Treatment study for children and adolescents with Acute Promyelocytic Leukemia Ended recruitment

2024-518669-83-00 4 2024-12-05 acute promyelocytic leukemia (APL) in children and adolescents
Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Subjects With Type 2 Diabetes Mell … Ended recruitment

2024-513539-25-00 4 2024-11-22 Type 2 Diabetes Mellitus
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis Ended recruitment

2024-512676-36-00 10 2024-10-09 Langerhans Cell Histiocytosis
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended recruitment

2022-501176-26-00 5 2023-08-04 Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
STEP Young: A research study on how well semaglutide helps children and teenagers with excess body weight lose weight Ended recruitment

2022-502922-41-00 5 2023-07-03 Obesity and overweight
LOGGIC/FIREFLY-2: DAY101 vs. Standard of Care Chemotherapy in Pediatric Patients with Low-Grade Glioma Requiring First-Line Systemic Therapy Ended recruitment

2024-510742-13-00 5 2023-04-19 Pediatric low-grade glioma harboring an activating RAF alteration requ
Ixekizumab Diabetes Intervention Trial (I-DIT) Ended recruitment

2023-508588-58-00 4 2022-10-25 Diabetes type 1
A Randomized Intervention, Multi-Center Study to Determine the Role of Dexamethasone eye drops against proliferative retinopathy of prematur … Ended recruitment

2023-505318-97-00 5 2022-09-22 Retinopathy of Prematurity
Acalabrutinib and rituximab in elderly patients with untreated mantle cell lymphoma (ALTAMIRA) Ended recruitment

2023-509864-96-00 4 2021-12-07 Mantle Cell Lymphoma (MCL)

Showing 73–96 of 129 trials